Histone deacetylase signaling in cardioprotection

Cardiovascular disease (CVD) represents a major challenge for health care systems, both in terms of the high mortality associated with it and the huge economic burden of its treatment. Although CVD represents a diverse range of disorders, they share common compensatory changes in the heart at the st...

Full description

Saved in:
Bibliographic Details
Main Authors: Lehmann, Lorenz (Author) , Jones, Barbara Christine (Author) , Stanmore, David (Author) , Backs, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 2014
In: Cellular and molecular life sciences
Year: 2014, Volume: 71, Issue: 9, Pages: 1673-1690
ISSN:1420-9071
DOI:10.1007/s00018-013-1516-9
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00018-013-1516-9
Get full text
Author Notes:Lorenz H. Lehmann, Barbara C. Worst, David A. Stanmore, Johannes Backs
Description
Summary:Cardiovascular disease (CVD) represents a major challenge for health care systems, both in terms of the high mortality associated with it and the huge economic burden of its treatment. Although CVD represents a diverse range of disorders, they share common compensatory changes in the heart at the structural, cellular, and molecular level that, in the long term, can become maladaptive and lead to heart failure. Treatment of adverse cardiac remodeling is therefore an important step in preventing this fatal progression. Although previous efforts have been primarily focused on inhibition of deleterious signaling cascades, the stimulation of endogenous cardioprotective mechanisms offers a potent therapeutic tool. In this review, we discuss class I and class II histone deacetylases, a subset of chromatin-modifying enzymes known to have critical roles in the regulation of cardiac remodeling. In particular, we discuss their molecular modes of action and go on to consider how their inhibition or the stimulation of their intrinsic cardioprotective properties may provide a potential therapeutic route for the clinical treatment of CVD.
Item Description:Published online: 06 December 2013
Gesehen am 08.12.2021
Physical Description:Online Resource
ISSN:1420-9071
DOI:10.1007/s00018-013-1516-9